Q&A: Oxford's Dagan Wells on the Adoption of Arrays for Preimplantation Genetic Screening

As a professor of obstetrics and gynecology at the University of Oxford and a laboratory director for the company Reprogenetics UK, Wells has seen the technologies used to test embryos for chromosomal abnormalities evolve from fluorescence in situ hybridization to array comparative genomic hybridization and, more recently, SNP genotyping.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.